###begin article-title 0
###xml 147 152 <span type="species:ncbi:9606">human</span>
Elevated endogenous expression of the dominant negative basic helix-loop-helix protein ID1 correlates with significant centrosome abnormalities in human tumor cells
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 236 241 <span type="species:ncbi:9606">human</span>
###xml 321 326 <span type="species:ncbi:9606">human</span>
ID proteins are dominant negative inhibitors of basic helix-loop-helix transcription factors that have multiple functions during development and cellular differentiation. Ectopic (over-)expression of ID1 extends the lifespan of primary human epithelial cells. High expression levels of ID1 have been detected in multiple human malignancies, and in some have been correlated with unfavorable clinical prognosis. ID1 protein is localized at the centrosomes and forced (over-)expression of ID1 results in errors during centrosome duplication.
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
Here we analyzed the steady state expression levels of the four ID-proteins in 18 tumor cell lines and assessed the number of centrosome abnormalities. While expression of ID1, ID2, and ID3 was detected, we failed to detect protein expression of ID4. Expression of ID1 correlated with increased supernumerary centrosomes in most cell lines analyzed.
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
This is the first report that shows that not only ectopic expression in tissue culture but endogenous levels of ID1 modulate centrosome numbers. Thus, our findings support the hypothesis that ID1 interferes with centrosome homeostasis, most likely contributing to genomic instability and associated tumor aggressiveness.
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 489 490 489 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 526 527 526 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 528 529 528 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 560 561 560 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 562 563 562 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 597 598 597 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 654 655 654 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 730 731 730 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 744 746 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 768 770 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 815 817 815 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 842 844 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1006 1007 1006 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1008 1010 1008 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1011 1013 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
The inhibitor of DNA-binding (ID) proteins, ID1-4, are negative regulators of basic Helix-Loop-Helix (bHLH) transcription factors. They lack the basic domain necessary for DNA-binding. By forming DNA-binding incompetent heterodimers with bHLH factors they inhibit transcription of target genes. Various cellular processes are regulated by individual ID-proteins: Inhibition of cellular differentiation by interference with differentiation-specific bHLH and non-bHLH transcription factors [1], extension of cellular life span [2-4], regulation of angiogenesis [5,6] as well as cardiac development [7] and maintenance of the embryonic stem cell phenotype [8]. ID expression is deregulated in many tumors, including cervical cancer [9], melanoma [10], pancreatic cancer [11], squamous cell carcinoma of the esophagus [12] and in thyroid cancer [13]. In some tumors ID-expression is associated with poor clinical prognosis, e.g. in ovarian cancer, in cervical cancer, in prostate cancer, and in breast cancer [9,14-17]. Taken together, these data imply an oncogenic role for ID proteins.
###end p 8
###begin p 9
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 689 691 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 824 826 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 866 868 866 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1080 1082 1080 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1083 1085 1083 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1382 1384 1382 1384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1500 1502 1500 1502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1680 1682 1680 1682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1683 1685 1683 1685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1774 1776 1774 1776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 1901 1903 1901 1903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 2012 2014 2012 2014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 2015 2017 2015 2017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 2018 2020 2018 2020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 2140 2142 2140 2142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 2143 2145 2143 2145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 100 105 <span type="species:ncbi:9606">human</span>
###xml 1647 1652 <span type="species:ncbi:9606">human</span>
Ectopic expression of ID1 rapidly leads to the accumulation of supernumerary centrosomes in primary human keratinocytes [18], induction of tetraploidy in telomerase-immortalized nasopharyngeal epithelial cells [19], and induction of chromosomal instability through deregulation of APC/Cdh1 in prostate epithelial cells [20]. A fraction of ID1, but not of the other ID proteins, is localized at centrosomal structures. ID1 is the only ID family member that shows a clear association with normal and supernumerary centrosomes throughout the cell cycle [18]. No centrosomal localization can be detected for ID2-4, irrespective of the cell cycle or centrosome duplication status of the cell ([18] and data not shown). Proposed mechanisms of how ID1 can induce centrosomal changes are deregulation of the centrosomal proteasome [21] and stabilization of aurora kinase A [19]. Centrosomes are the microtubule organizing centers (MOC) of the cell and consist of two centrioles surrounded by pericentriolar material containing different coiled-coil proteins, e.g. pericentrin and ninein [22-25]. Centrosome duplication is a critical event during mitosis, as it must only happen once to ensure the formation of a bipolar mitotic spindle and equal segregation of chromosomes during mitosis. Duplication is initiated at the G1-S-phase transition and is controlled by CDK2-Cyclin E/A activity [24]. Furthermore, phosphorylation of pRB seems to be necessary followed by the activity of E2F transcription factors [26]. Centrosome abnormalities are found in neurodegenerative processes as well as in autoimmune diseases, but most frequently they are observed in human malignancies (reviewed in [22,27]). In normal cells centrosome defects lead to G1 arrest of the cell via p53 activation [28]. Tumor cells with mutated p53 lack this mechanism and can still undergo mitosis and thereby accumulate centrosome defects [29]. Furthermore, various cellular and viral oncogenes can induce centrosome abnormalities independent of p53 [18,30-32]. Supernumerary centrosomes lead to the formation of abnormal multipolar mitoses and may ultimately induce aneuploidy [33-35].
###end p 9
###begin p 10
Here, we analyzed endogenous ID expression levels in various (tumor) cell lines. By assessing the number of centrosomes we show here that high endogenous ID1 expression, but not that of the other ID proteins, is associated with a higher rate of abnormal centrosomes. This lends further support to the hypothesis that ID1 interferes with centrosomal function and can promote a more aggressive tumor phenotype.
###end p 10
###begin title 11
Results
###end title 11
###begin p 12
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 37 42 <span type="species:ncbi:9606">human</span>
Ectopic expression of ID1 in primary human cells results in accumulation of supernumerary centrosomes in these cells [18]. High expression levels of the ID-proteins have been observed in various proliferating tissue types [36]. As there are several, partly contradictory reports about the expression levels of the four ID-proteins in primary tumor cells and cell lines, we analyzed 18 established (tumor) cell lines for endogenous ID protein expression levels in proliferating cells.
###end p 12
###begin title 13
ID proteins are differentially expressed in tumor cell lines
###end title 13
###begin p 14
###xml 237 238 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1A</xref>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1B</xref>
###xml 1024 1026 1024 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1C</xref>
###xml 1093 1095 1093 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1D</xref>
###xml 1172 1174 1172 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
Protein expression levels of the four ID-proteins were analyzed in proliferating cells using standard Western blotting technique. Cell cycle analysis confirmed similar cell cycle distribution of the different cell lines (Additional File 1). ID protein expression was normalized to GAPDH-expression. Expression of ID1 was readily detectable in all cervical cancer cell lines, in HaCaT, in the colon cancer line HCT-15 as well as in Jurkat (lymphocytic leukemia) (Figure 1A). Intermediate expression of ID1 could be detected in the remaining leukemic cell lines and in two breast cancer cell lines, T47-D and MDA-MB453, whereas MCF-7 and MDA-MB468 only showed very low ID1 expression. ID2 protein expression could be detected in most cell lines (Figure 1B). Only CaSki, a cervical cancer cell line, H-2171 (SCLC), and the osteosarcoma cell line U2OS did not express ID2 in remarkable levels. In contrast higher ID3 expression was only detectable in a small number of cells, i.e. in Jurkat, HaCaT, HeLa, and C33A cells (Figure 1C). ID4 protein was undetectable in all examined cell lines (Figure 1D) confirming earlier reports that ID4 is mainly expressed in neural tissues [37].
###end p 14
###begin p 15
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Endogenous ID expression in different cell lines</bold>
###xml 50 53 50 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A) </bold>
###xml 107 110 107 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B) </bold>
###xml 162 165 162 165 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C) </bold>
###xml 215 218 215 218 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D) </bold>
Endogenous ID expression in different cell lines. A) Expression analysis of ID proteins in leukemic cells. B) Expression of ID proteins in cervical cancer cells. C) Expression of ID proteins in breast cancer cells. D) Expression of ID proteins in other epithelial cells. Cells were grown up to 70% confluence and harvested for protein. Protein extracts (10 mug) were then submitted to western blot analysis. Primary antibodies used were anti-ID1, anti-ID2, anti-ID3 and anti-ID4, GAPDH expression as loading control. Examined cell lines and their characteristics are summarized in Additional File 3.
###end p 15
###begin title 16
ID-mRNA expression does not correlate with protein expression
###end title 16
###begin p 17
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2A</xref>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2B</xref>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2C</xref>
###xml 1046 1048 1046 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2D</xref>
To compare mRNA expression of the ID proteins with protein expression, quantitative real time PCR (qRT-PCR) was performed on selected cell lines using ID-specific primer pairs. We observed different ID mRNA expression patterns as compared to ID protein expression patterns (Figure 2). ID1 mRNA expression could be detected at similar levels in all cell lines (Figure 2A). ID2 mRNA expression was readily detectable in all cell lines. Here, only Jurkat seemed to express lower levels of ID2 mRNA, which is in contrast to the relatively high ID2 protein expression in these cells (Figure 2B). ID3 mRNA expression correlated with the ID3 protein expression levels in all cell lines but HCT-15, where the highest mRNA-expression but low protein expression of ID3 was seen (Figure 2C). Most cell lines analyzed showed undetectable ID4 mRNA levels, a finding correlating with non-detectable ID4 protein expression in these cells. Surprisingly, HaCaT cells express high levels of ID4 mRNA, which did not translate into higher ID4 protein levels (Figure 2D).
###end p 17
###begin p 18
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ID mRNA expression in 5 selected cell lines, assessed by qRT-PCR</bold>
###xml 209 222 209 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-&#916;&#916;Ct</sup>
ID mRNA expression in 5 selected cell lines, assessed by qRT-PCR; ID-specific primers were used, shown is the mean of at least two independent experiments, bars represent standard deviation; relative values (2-DeltaDeltaCt) were calculated using SiHa cells as control cell line, therefore ID mRNA expression was first related to GAPDH mRNA expression in each cell line (DeltaCtq), following relation to ID mRNA expression in SiHa cells (DeltaDeltaCt), then submitted to the above mentioned term; A) ID1 mRNA; B) ID2 mRNA; C) ID3 mRNA; D) ID4 mRNA.
###end p 18
###begin title 19
Analysis of centrosome number
###end title 19
###begin p 20
###xml 575 580 <span type="species:ncbi:9606">human</span>
To address the question whether endogenous ID1 can contribute to accumulation of supernumerary centrosomes, as has been reported for ectopic ID1 expression, the number of centrosomes was determined using immunofluorescence microscopy. A monoclonal antibody against gamma-tubulin, a component of the pericentriolar matrix was used to visualize centrosomes. Only cells with one nucleus were analyzed and n > 2 centrosomes per cells were counted as having supernumerary centrosomes. We know from previous experiments that the rate of abnormal centrosomes is approximately 2% in human foreskin keratinocytes. Therefore we assumed a rate of centrosomal abnormalities of > 2% as aberrant.
###end p 20
###begin p 21
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3G</xref>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3B</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3E</xref>
###xml 463 468 463 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3C, F</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3H</xref>
###xml 556 558 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3D</xref>
###xml 685 686 685 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 1012 1013 1002 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 1114 1115 1104 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1201 1202 1191 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 1792 1794 1782 1784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 1778 1783 <span type="species:ncbi:9606">human</span>
Analysis of centrosome number in leukemic cells showed the highest percentage of cells with aberrant centrosomes in Jurkat, followed by HL-60 and U937. Kazumi cells had the lowest percentage of supernumerary centrosomes (Figure 3A &3G). All cervical cancer cells showed a higher percentage of aberrant centrosomes, ranging from 6.5% (SiHa) to 11% (C33A) (Figure 3B &3E). Breast cancer cells showed similar centrosome abnormalities with exception of T47-D (Figure 3C, F &3H). The other tested cell lines showed very heterogeneous centrosome numbers (Figure 3D). The highest numbers of abnormal centrosomes (>9%) were detected in Jurkat, T 47-D, C33A and HeLa cells (summarized in Table 1). An intermediate frequency could be observed in HaCaT, CaSki and HCT-15 with 8.7% (STD +/- 1.9), 8.8% (STD +/- 1.1) and 8.3% (STD +/- 3.3) of supernumerary centrosomes. The remaining cell lines showed a lower number of abnormal centrosomes ranging from 6.6% (+/- 2.0) in MDA-MB453 to 2.9% (+/- 0.2) in Kasumi-1 cells (Table 1). Higher ID1 expression correlated with more pronounced centrosomal colocalization (Additional File 2). Centrosome number did not influence the rate of mono- or multipolar mitoses (Table 1). The group of David Pellman recently proposed a direct mechanism by which supernumerary centrosome could induce chromosomal instability: Using long-term live-cell imaging Ganem and colleagues could demonstrate that cells with multiple centrosomes rarely undergo multipolar cell divisions, but routinely undergo bipolar cell divisions. Furthermore, the authors could convincingly show that extra centrosomes alone are sufficient to promote chromosome missegregation during bipolar cell division, and propose this to be the mechanism and the common underlying cause of CIN in human cancer [38].
###end p 21
###begin p 22
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Assessment of centrosome numbers in established cell lines</bold>
###xml 222 225 222 225 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A) </bold>
###xml 295 298 295 298 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B) </bold>
###xml 375 378 375 378 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C) </bold>
###xml 453 456 453 456 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D) </bold>
###xml 534 566 534 566 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E-H: Immunofluorescence analysis</bold>
###xml 822 825 818 821 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E) </bold>
###xml 893 896 889 892 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F) </bold>
###xml 978 981 974 977 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G) </bold>
###xml 1051 1054 1047 1050 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H) </bold>
Assessment of centrosome numbers in established cell lines. Quantitative analysis of centrosome abnormalities and abnormal mitoses depicted as mean of at least 3 independent experiments, bars represent standard deviation. A) Percentage of cells with supernumerary centrosomes in leukemic cells. B) Percentage of cells with supernumerary centrosomes in cervical cancer cells. C) Percentage of cells with supernumerary centrosomes in breast cancer cells. D) Percentage of cells with supernumerary centrosomes in other epithelial cells. E-H: Immunofluorescence analysis. Centrosomes were visualized using gamma-tubulin antibody (green); nuclei were visualized using Hoechst 33258 (blue); for each group of cell lines representative examples of normal (left picture) and abnormal (right picture) centrosome numbers are shown; E) Cell lines with a high rate of centrosomal abnormalities, e.g. C33A F) Cell lines with an intermediate rate of centrosomal abnormalities, e.g. MDA-MB468 G) Cell lines with a low rate of centrosome abnormalities, e.g. Kasumi-1 H) Cell lines with a high number of abnormal centrosomes and mitoses, e.g. T47-D.
###end p 22
###begin p 23
Summary of ID expression analysis, centrosome abnormalities and abnormal mitoses.
###end p 23
###begin p 24
Cell lines are lined up starting with highest rate of centrosomal abnormalities. +: high expression; (+): intermediate expression; -: Low expression or not detectable.
###end p 24
###begin title 25
High ID1 expression correlates with increased centrosomal abnormalities
###end title 25
###begin p 26
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4A</xref>
###xml 911 912 907 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
We have previously reported accumulation of supernumerary centrosomes in cells ectopically expressing ID1 [18,21]. No influence of ID2, ID3 or ID4 was detected then. Our findings here were very suggestive that endogenous ID1 expression might also influence centrosomal homeostasis in various cancer cell lines. Comparison of ID1 expression and the number of centrosomal abnormalities showed a clear and significant correlation of high ID1-expression with an increased number of centrosome abnormalities (Figure 4A) (Spearman's rank correlation coefficient p = 0.66804). Surprisingly, not only ID1 expression but also ID3 expression correlated with centrosome abnormalities (Spearman's coefficient p = 0.61976), whereas ID2 and ID4 did not. Similarly, colocalization of ID1 with centrosomes (i.e. with gamma-tubulin) was more obvious in leukemic cells expressing higher levels of endogenous ID1 (Additional file 1).
###end p 26
###begin p 27
###xml 0 27 0 27 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Statistical data evaluation</bold>
###xml 29 32 29 32 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A) </bold>
###xml 115 118 115 118 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B) </bold>
Statistical data evaluation. A) Logarithmic ID1 expression data compared with number of centrosomal abnormalities; B) Spearman's rank correlation coefficient r looking at ID expression and centrosome abnormalities: r values above, p values below; r = 1 shows perfect correlation, r = 0 shows no correlation, 1> r > 0 shows positive correlation, in this case e.g. ID1 and centrosomal abnormalities.
###end p 27
###begin p 28
Taken together, elevated endogenous ID1 expression, as seen in diverse cancer cell lines, is associated with an increased number of centrosome abnormalities. Furthermore we have shown here that all ID proteins, except ID4, are expressed in cancer cell lines and that protein expression does not strictly correlate with mRNA expression, most likely due to post-translational modifications and/or ID protein stability and dynamics. Our findings confirm a role of ID proteins in the regulation of centrosome duplication and raise the question of how protein expression of the ID-proteins beyond transcription is regulated.
###end p 28
###begin title 29
Discussion
###end title 29
###begin p 30
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 812 814 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 960 962 960 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
Although it has been reported that ectopic expression of ID1 but not ID2-4 leads to rapid induction of cells with supernumerary centrosomes [18,19,21] one cannot rule out that this is due to the experimental conditions. We therefore analyzed ID expression in different cell types using immunoblot and real time PCR to correlate endogenous ID expression with centrosome abnormalities. Apart from ID2, which showed a uniform expression pattern in breast cancer and leukemic cells, we did not detect a clear tissue specific expression pattern of the IDs. ID2 is induced in the course of normal granulopoesis [39,40]. ID2 can also be induced by myc through direct promoter activation [41]. Both leukemic cell lines, HL-60 and U937, express myc at high levels, which might explain high ID2 expression in these cells [42]. In addition, ID2 can be induced by HIF-1 and HIF-2 (Hypoxia induced factors), which might contribute to ID2 expression in breast cancer cells [43].
###end p 30
###begin p 31
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 644 652 <span type="species:ncbi:9606">patients</span>
ID3 protein was expressed in a minority of cells, and ID4 protein expression was undetectable in all cell lines analyzed, confirming earlier results [37]. Whether ID4 positively influences tumor growth is still not completely understood. Recent studies revealed that the ID4 gene can be silenced through promoter hypermethylation in various tumors [44-48], suggesting a tumor suppressive role. On the other hand ID4 was identified as an upstream regulator of BRCA1 in breast and ovarian cancer, and more aggressive breast cancer types showed higher ID4 expression [49]. Additionally, activating translocations of ID4 have been detected in some patients and a subset of acute lymphoblastic leukemia [50-52].
###end p 31
###begin p 32
###xml 777 779 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 780 782 780 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 938 940 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 941 943 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 1132 1134 1132 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 1135 1137 1135 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
###xml 1252 1254 1252 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
ID1 protein expression was readily detectable in most of the cell lines analyzed. Expression was independent of cell cycle distribution or underlying mutations. Since cells were cultured simultaneously under the same conditions, differential induction of ID1 by growth factors from the culture medium is also unlikely. Other factors e.g. proteasomal degradation, RNA stability, microRNAs, posttranscriptional and posttranslational modifications, or gene amplification might regulate ID1 expression. The observed differences between ID protein and mRNA expression imply that ID mRNA or proteins are altered soon after transcription or after translation. ID1, ID2 and ID3 are degraded via the ubiquitin-proteasome complex while ID4 seems to be eliminated through other pathways [53-55]. The half-life of ID proteins, namely ID1 and ID3 is relatively short, depending on the cell type and cell cycle status. It ranges from 30 to 60 minutes [53-55]. Additionally the biological activity of ID2 and ID3 can be altered by phosphorylation, which occurs in late G1 and alters the binding specificity and the stability of these ID proteins [56,57]. By altering the proteasome activity or by accelerating ubiquitination ID protein degradation could be promoted [58]. Intracellular miRNAs or siRNAs might trigger ID mRNA degradation or inhibit translation. Thus, to measure biological activity of the IDs and to further analyze their role in tumor development, protein expression should be determined rather than mRNA expression.
###end p 32
###begin p 33
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B61">61</xref>
###xml 581 591 581 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Waf1/Cip1 </sup>
###xml 598 602 598 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 680 689 680 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Waf1/Cip1</sup>
###xml 818 828 818 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Waf1/Cip1 </sup>
###xml 847 849 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 925 927 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 928 930 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B62">62</xref>
###xml 931 933 931 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B63">63</xref>
###xml 1062 1064 1062 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B64">64</xref>
###xml 1137 1139 1137 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 950 955 <span type="species:ncbi:9606">human</span>
We show here that elevated endogenous ID1 expression levels correlate with the accumulation of abnormal centrosomes. Interestingly, a statistical correlation between ID3 expression and ID1 expression and therefore between ID3 and centrosomal abnormalities was found, which might be due to co-regulation of ID1 and ID3 [59]. Centrosome duplication is orchestrated by cyclins, cyclin-dependent kinases and their inhibitors [60], and loss of the latter results in centriole over duplication [61]. As ID proteins influence members of the cyclin-inhibiting Cip and Kip factors, e.g. p21Waf1/Cip1 and p27Kip1, one might assume that ID1 induces centrosome abnormalities by inhibiting p21Waf1/Cip1. This seems unlikely, as only ectopic expression of ID1 leads to centrosomal abnormalities, whereas all ID proteins regulate p21Waf1/Cip1 promoter activity [18]. Other (proto)oncogenes such as myc can induce centrosomal abnormalities [21,62,63]. The high-risk human papilloma virus (HPV) E6 and E7 oncoproteins lead to genomic instability and induce abnormal centrosomes [64]. Cervical cancer is most often caused by infection with high-risk HPV [65]. All cervical cancer cell lines analyzed showed high levels of abnormal centrosomes. Interestingly, the highest rate of supernumerary centrosomes was detected in C33A cells, which are HPV negative. Therefore, another mechanism must contribute to accumulation of abnormal centrosomes in these cells, e.g. high expression levels of ID1.
###end p 33
###begin p 34
###xml 457 459 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 591 593 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 753 755 753 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1137 1139 1137 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B66">66</xref>
###xml 1140 1142 1140 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B68">68</xref>
###xml 1356 1358 1356 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B69">69</xref>
###xml 1359 1361 1359 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B71">71</xref>
One mechanism that ID1 can deregulate centrosome duplication is by regulating the activity of the centrosomal proteasome. This is in part mediated through interaction of ID1 with S5a, a subunit of the 26S proteasome. ID1 and S5A are both located at centrosomal structures. Ectopic expression of S5a normalizes ID1-induced centrosome abnormalities, and depletion of S5a leads to a similar accumulation of supernumerary centrosomes without tetraploidization [21]. Development of centrosomal alterations and cell aneuploidy has been linked to overexpression of the centrosomal kinase Aurora A [20]. Indeed, it has been shown that ID1 overexpression may lead to stabilization of Aurora A by interaction with the anaphase-promoting complex coactivator Cdh1 [20]. Thus, high levels of ID1 may interact with Cdh1 to stabilize Aurora-A and induce supernumerary centrosomes. The interactions between Aurora kinases and ID1 require further functional in vitro analyses. Aurora-A is differentially regulated and expressed in chromosomal and microsatellite instable colorectal carcinomas and the observed high ID1 expression may contribute to this [66-68]. Recent efforts of therapeutic intervention with small molecule inhibitors of Aurora kinase are ongoing, and the data presented here may provide additional information about the potential therapeutic mechanisms [69-71].
###end p 34
###begin p 35
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S3">3</xref>
###xml 685 686 685 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S3">3</xref>
###xml 929 931 929 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
We did not observe a correlation between aneuploidy and increased abnormal centrosomes. Nearly all cell lines analyzed had aneuploid karyotypes (Additional File 3) but not all of them are characterized by high levels of centrosome abnormalities. Even the rate of aneuploidy does not seem to influence the frequency of abnormal centrosomes as MCF-7 and MDA-MB453 reveal only slightly elevated levels of abnormal centrosomes accompanying aneuploidy. Altered p53 function contributes to impaired centrosome function. Only four of the cell lines used (T47-D, MCF-7, U2OS, Kasumi-1) have wild type p53, whereas all other cell lines harbor a mutated or inactivated p53 gene (Additional File 3). We failed to see an influence of p53 status on steady state centrosome numbers. As previously shown, ID1 appears to act independent of p53 as it is able to induce centrosomal abnormalities in p53 deficient as well as in p53 positive cells [18].
###end p 35
###begin title 36
Conclusions
###end title 36
###begin p 37
Taken together we show here that not only ectopic but also endogenous ID1 expression can deregulate centrosome duplication, further supporting an oncogenic role for this ID protein. This is in so far of importance, as most knowledge about the function of ID proteins comes from overexpression experiments, in which non-physiologically high expression levels were used to achieve biological effects. Furthermore, when evaluating ID expression in tumors and cell lines, protein levels should be analyzed and correlated with mRNA expression. Our results might imply that protein expression of the IDs is more complex than previously thought and that protein expression and not mRNA-expression should be the main focus of further expression analysis in primary tumors.
###end p 37
###begin title 38
Methods
###end title 38
###begin title 39
Cell culture
###end title 39
###begin p 40
###xml 642 648 <span type="species:ncbi:9913">bovine</span>
Cell lines used were HL-60, Jurkat, U937, Kasumi-1, SiHa, HeLa, CaSki, C33A, MDA-MB468, MDA-MB453, T47-D, MCF-7, HaCaT, U2OS, 293T, NCIH295, HCT-15 and H-2171. L-60, Jurkat, U937, Kasumi-1, MDA-MB453, MCF-7, HCT-15, and H-2171 were maintained in RPMI 1640 medium. NCIH295 cells were grown in RPMI 1640 medium supplemented with 1% insuline-transferrine-selenium-solution. All cervical cancer cell lines (SiHa, HeLa, CaSki, C33A), and T47-D, MDA-MB468, 293T, HaCaT, and U2OS were grown in D-MEM. Medium was supplemented with an antibiotic-antimycotic mixture (streptomycin, penicillin) and 10% (vol/vol) or 15% (NCIH295) heat-inactivated fetal bovine serum. Cells were grown at 37degreesC, 5% CO2 and 95% vapor-saturated atmosphere.
###end p 40
###begin title 41
Plasmids
###end title 41
###begin p 42
###xml 90 91 90 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
Vectors used were pCMV-ID1 (p1121), pCMV-ID2 (p1122), pCMV-ID3 (p1123), pCMV-ID4 (p1124) [2].
###end p 42
###begin title 43
Transfection
###end title 43
###begin p 44
U2OS cells were transfected with Fugene 6 (Boehringer Mannheim) according to the manufacturers directions. Cells were harvested for analysis 48 h after transfection.
###end p 44
###begin title 45
Cell harvesting and Western Blotting
###end title 45
###begin p 46
###xml 807 818 <span type="species:ncbi:3704">horseradish</span>
Cell lines were grown in 100-mm tissue culture plates to approximately 70% confluence and harvested. After three washes with ice-cold PBS (Gibco) cells were lysed with 100 to 250 mul of lysis buffer (0,5% NP-40 lysis buffer, 50 mM Tris HCl pH 7,4, 150 mM NaCl, and protease and phosphatase inhibitors). Cell lysates were clarified by centrifugation and quantitated by the Bio-Rad DC protein assay system. Samples were then boiled in SDS sample buffer, and equal amounts of proteins were separated by SDS-polyacrylamide gel electrophoresis with 15% acrylamide and transferred to Hybond P membranes (Amersham) for Western blotting analysis. Primary antibodies used included Id1 (C-20), ID2 (C-20), Id3 (H-70), ID4 (H-70) and GAPDH (FL-335) (Santa Cruz, Santa Cruz, CA, USA). Bound proteins were detected with horseradish peroxidase-conjugated secondary antibodies (Santa Cruz, Santa Cruz, CA, USA). After extensive washing of the membrane, fluorescent signal was detected by ECL reagent (Amersham, Braunschweig, Germany), followed by exposure to film (Amersham Hyperfilm ECL, Braunschweig, Germany).
###end p 46
###begin title 47
Image J program
###end title 47
###begin p 48
Image J software (Wayne Rasband, National Institute of Mental Health, Bethesda, Maryland, USA) was used to evaluate protein expression. ID expression was normalized to GAPDH expression in each cell line.
###end p 48
###begin title 49
Immunofluorescence
###end title 49
###begin p 50
###xml 168 172 <span type="species:ncbi:9925">goat</span>
###xml 457 461 <span type="species:ncbi:9925">goat</span>
###xml 467 473 <span type="species:ncbi:9986">rabbit</span>
Cells were grown on cover slips to a confluence of 70%, washed with ice-cold PBS and fixed with methanol for 20 minutes at -20degreesC. After preincubation with normal goat serum for 20 minutes at room temperature to block unspecific protein binding, cells were incubated with primary antibody gamma-Tubulin (Sigma, Deisenhofen, Germany) overnight at -4degreesC. On the next day the cells were incubated for 2 hours with secondary antibody Alexa Fluor 488 (goat-anti-rabbit) (Molecular Probes, Eugene, Oregon, USA) at 37,0degreesC in a humid chamber. After visualization of nuclei using Hoechst 33258, cover slips were mounted to microscope slides and analyzed using a Zeiss Axioplan confocal microscope. Only mononuclear (i.e. cells containing only one nucleus) cells were analyzed for centrosome number and rate of abnormal mitoses. A minimum of 15 high power fields with at least 20 cells per field was analyzed per cell line. To visualize ID-proteins the above mentioned antibodies were used (1:100 dilution in PBS), then fluorescence labeled secondary antibody Alexa Fluor 568 (Molecular Probes, Eugene, Oregon, USA) was applied (1:200 dilution in PBS).
###end p 50
###begin title 51
RNA isolation
###end title 51
###begin p 52
Cells were grown in 100 mm-tissue culture plates to 70% confluence and total RNA was isolated with the RNeasy MicroKit (Qiagen) according to the manufacturers directions. RNA concentration and purity was assessed by spectrophotometry.
###end p 52
###begin title 53
Real-time PCR
###end title 53
###begin p 54
###xml 1210 1224 1210 1216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-&#916;&#916;Ct </sup>
###xml 1232 1234 1224 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B72">72</xref>
###xml 1570 1583 1546 1551 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-&#916;&#916;Ct</sup>
Primer pairs (ID1 Forward: 5' TCC AGC ACG TCG ACT ACA 3', ID1 Reverse: 5' GGG TTC CAA CTT CGG ATT CC 3', ID1 Probe: 5' 6-Fam CAG GGA CCT TCA GTT GG MGB 3'; ID2 Forward: 5' CCA CCC TCA ACA CGG ATA TCA 3', ID2 Reverse: 5' CAC AGT GCT TTG CTG TCA TTT G 3', ID2 Probe: 5' 6-Fam TGT CCT TGC AGG CTT CTG MGB 3'; ID3 Forward: 5' CCC CAC CTT CCC ATC CA 3', ID3 Reverse: 5' CAG TGG CAA AAG CTC CTT TTG 3', ID3 Probe: 5' 6-Fam GAC AGC CGA GCT CAC MGB 3'; ID4 Forward: 5' TCC CGC CCA ACA AGA AAG 3', ID4 Reverse: 5' GGT CCA GGA TGT AGT CGA TAA CG 3', ID4 Probe: 5' 6-Fam AGC AAA GTG GAG ATC C MGB 3' were designed using Primer Express (Applied Biosystems). Quantitative reverse transcription-PCR was performed on DNase-treated RNA using the TaqMan Assay (Applied Biosystems) according to the manufacturer's directions. Amplification of target sequences was detected with an ABI 7000 sequence detection system (Applied Biosystems) and analyzed with SDS 2.0 software (Applied Biosystems). The cycle threshold (Ct) was determined as the number of PCR cycles required for a given reaction to reach an arbitrary fluorescence value within the linear amplification range. Relative quantification was performed according to the 2-DeltaDeltaCt method [72], with GAPDH serving as reference and ID1-4 as target genes. First, target and reference CT-values were subtracted from each other (DeltaCT) for each sample, followed by subtraction of DeltaCT-values of the cell line samples from the reference (SiHa cell line) sample yielding DeltaDeltaCT and final calculation of the fold change by 2-DeltaDeltaCt.
###end p 54
###begin title 55
FACS analysis
###end title 55
###begin p 56
Cellular DNA content and cell cycle distribution was measured using a Dako Cytomation FACS sorter. After trypsinization cells were pelleted and fixed with 100% ethanol over night. The following day cells were incubated with RNAse A and Propidium iodide for 30 minutes and then subjected to FACS.
###end p 56
###begin title 57
Statistical analysis
###end title 57
###begin p 58
Data are provided as mean +/- SEM. To determine the correlation between centrosomal abnormalities and ID expression Pearson's correlation coefficient and Spearman's coefficient were calculated following the conversion of ID expression data into logarithmic values. Furthermore r-square was determined to distinguish whether centrosomal abnormalities could be explained by changes of ID expression.
###end p 58
###begin title 59
Authors' contributions
###end title 59
###begin p 60
CM did the primary expression analysis and cell analysis and manuscript writing. DSM helped establishing the techniques. AG and AJZ helped with protein expression and cell culture. CH designed the primers and established PCR techniques. SL contributed conceptually and wrote the final manuscript. JH conceptualized the study, helped with experimental procedures, and assessments of the results, wrote and finalized the manuscript. All authors approved the final manuscript.
###end p 60
###begin title 61
Supplementary Material
###end title 61
###begin title 62
Additional file 1
###end title 62
###begin p 63
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FACS analysis of SiHa, MCF-7, and T47-D cell lines</bold>
###xml 212 213 212 213 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 221 222 221 222 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 234 235 234 235 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
FACS analysis of SiHa, MCF-7, and T47-D cell lines. DNA content of the cells was evaluated using FACS sorting (Dako Cytomation) after cells were treated with RNAse and Propidium iodide. Representative example of A) SiHa, B) MCF-7 and C) T47-D DNA content (64 corresponds to a single set of chromosomes (G1, G0), 128 to a doubled set of chromosomes (G2), counts in between show cells in S phase.
###end p 63
###begin p 64
Click here for file
###end p 64
###begin title 65
Additional file 2
###end title 65
###begin p 66
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Comparison of HL-60 and Jurkat leukemic cell lines</bold>
###xml 52 55 52 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A) </bold>
###xml 188 191 184 187 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B) </bold>
###xml 341 344 335 338 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C) </bold>
Comparison of HL-60 and Jurkat leukemic cell lines. A) Co-Immunofluorescence analysis subcellular localization of ID1 and gamma-tubulin; nuclei were visualized using Hoechst 33258 (blue). B) Quantitative analysis of cells with n > 2 centrosomes and percent mitotic cells (mean of at least 3 independent experiments, +/- standard deviation). C) ID1 protein expression in HL-60 and Jurkat cells. Protein extracts (10 mug) were analyzed by immuno blotting using primary antibodies against ID1 (C-20), and GAPDH (loading control).
###end p 66
###begin p 67
Click here for file
###end p 67
###begin title 68
Additional file 3
###end title 68
###begin p 69
###xml 0 5 0 5 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table</bold>
Table. Characteristics of cell lines used.
###end p 69
###begin p 70
Click here for file
###end p 70
###begin title 71
Acknowledgements
###end title 71
###begin p 72
The authors acknowledge the excellent technical support of Anja Schopflin and thank Jurgen Schulte Monting for assisting in the statistical analyses. This work was in part supported by the German Research Foundation (DFG, grant LA 1290/3-1 to SL and grant HA3185/2-1 and 2-3 to JH) and the Mushett Family Foundation (Chester, New Jersey, US).
###end p 72
###begin article-title 73
Id: a negative regulator of helix-loop-helix DNA binding proteins. Control of terminal myogenic differentiation
###end article-title 73
###begin article-title 74
###xml 27 32 <span type="species:ncbi:9606">human</span>
Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1
###end article-title 74
###begin article-title 75
Id-1 delays senescence but does not immortalize keratinocytes
###end article-title 75
###begin article-title 76
###xml 76 81 <span type="species:ncbi:9606">human</span>
The helix-loop-helix protein id-1 delays onset of replicative senescence in human endothelial cells
###end article-title 76
###begin article-title 77
Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts
###end article-title 77
###begin article-title 78
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth
###end article-title 78
###begin article-title 79
Rescue of cardiac defects in id knockout embryos by injection of embryonic stem cells
###end article-title 79
###begin article-title 80
BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3
###end article-title 80
###begin article-title 81
Overexpression of id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer
###end article-title 81
###begin article-title 82
The Transcriptional Repressor of p16/Ink4a, Id1, Is Up-Regulated in Early Melanomas
###end article-title 82
###begin article-title 83
Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis
###end article-title 83
###begin article-title 84
Identification of Differentially Expressed Genes in Esophageal Squamous Cell Carcinoma (ESCC) by cDNA Expression Array: Overexpression of Fra-1, Neogenin, Id-1, and CDC25B Genes in ESCC
###end article-title 84
###begin article-title 85
###xml 38 43 <span type="species:ncbi:9606">human</span>
Id1 gene expression and regulation in human thyroid tissue
###end article-title 85
###begin article-title 86
Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer
###end article-title 86
###begin article-title 87
Over expression of ID-1 in prostate cancer
###end article-title 87
###begin article-title 88
Level of id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors
###end article-title 88
###begin article-title 89
Expression of the inhibitor of DNA-binding (ID)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers
###end article-title 89
###begin article-title 90
The helix-loop-helix protein ID1 localizes to centrosomes and rapidly induces abnormal centrosome numbers
###end article-title 90
###begin article-title 91
Id1 overexpression induces tetraploidization and multiple abnormal mitotic phenotypes by modulating aurora A
###end article-title 91
###begin article-title 92
Id-1 promotes chromosomal instability through modification of APC/C activity during mitosis in response to microtubule disruption
###end article-title 92
###begin article-title 93
Interference of the dominant negative helix-loop-helix protein ID1 with the proteasomal subunit S5A causes centrosomal abnormalities
###end article-title 93
###begin article-title 94
Centrosome aberrations: cause or consequence of cancer progression?
###end article-title 94
###begin article-title 95
The centrosome cycle
###end article-title 95
###begin article-title 96
Two for two: Cdk2 and its role in centrosome doubling
###end article-title 96
###begin article-title 97
Duplicating dangerously: linking centrosome duplication and aneuploidy
###end article-title 97
###begin article-title 98
Centrosome duplication in mammalian somatic cells requires E2F and Cdk2-cyclin A
###end article-title 98
###begin article-title 99
Centrosomes in cellular regulation
###end article-title 99
###begin article-title 100
Loss of centrosome integrity induces p38-p53-p21-dependent G1-S arrest
###end article-title 100
###begin article-title 101
Abnormal centrosome amplification in the absence of p53
###end article-title 101
###begin article-title 102
Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression
###end article-title 102
###begin article-title 103
E1A deregulates the centrosome cycle in a Ran GTPase-dependent manner
###end article-title 103
###begin article-title 104
###xml 0 28 <span type="species:ncbi:333760">Human papillomavirus type 16</span>
Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of inactivation of retinoblastoma protein family members
###end article-title 104
###begin article-title 105
Centrosome replication, genomic instability and cancer
###end article-title 105
###begin article-title 106
A tale of too many centrosomes
###end article-title 106
###begin article-title 107
Deregulation of the centrosome cycle and the origin of chromosomal instability in cancer
###end article-title 107
###begin article-title 108
ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis
###end article-title 108
###begin article-title 109
The expression pattern of Id4, a novel dominant negative helix-loop-helix protein, is distinct from Id1, Id2 and Id3
###end article-title 109
###begin article-title 110
A mechanism linking extra centrosomes to chromosomal instability
###end article-title 110
###begin article-title 111
Differential regulation of granulopoiesis by the basic helix-loop-helix transcriptional inhibitors Id1 and Id2
###end article-title 111
###begin article-title 112
###xml 49 54 <span type="species:ncbi:9606">human</span>
Id2 expression increases with differentiation of human myeloid cells
###end article-title 112
###begin article-title 113
Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins
###end article-title 113
###begin article-title 114
Identification and characterization of rapidly dividing U937 clones with differential telomerase activity and gene expression profiles: role of c-Myc/Mad1 and Id/Ets proteins
###end article-title 114
###begin article-title 115
Induction of ID2 expression by hypoxia-inducible factor-1: a role in dedifferentiation of hypoxic neuroblastoma cells
###end article-title 115
###begin article-title 116
###xml 91 96 <span type="species:ncbi:9606">human</span>
Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer
###end article-title 116
###begin article-title 117
Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma
###end article-title 117
###begin article-title 118
Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis
###end article-title 118
###begin article-title 119
Frequent DNA methylation but not mutation of the ID4 gene in malignant lymphoma
###end article-title 119
###begin article-title 120
Aberrant promoter CpG islands methylation of tumor suppressor genes in cholangiocarcinoma
###end article-title 120
###begin article-title 121
Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach
###end article-title 121
###begin article-title 122
Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer
###end article-title 122
###begin article-title 123
Id4 is deregulated by a t(6;14)(p22;q32) chromosomal translocation in a B-cell lineage acute lymphoblastic leukemia
###end article-title 123
###begin article-title 124
t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)
###end article-title 124
###begin article-title 125
Degradation of Id proteins by the ubiquitin-proteasome pathway
###end article-title 125
###begin article-title 126
Proteasome mediated degradation of Id-1 is associated with TNFalpha-induced apoptosis in prostate cancer cells
###end article-title 126
###begin article-title 127
Ubiquitin-Proteasome-mediated degradation of Id1 is modulated by MyoD
###end article-title 127
###begin article-title 128
Regulation of Id3 cell cycle function by Cdk-2-dependent phosphorylation
###end article-title 128
###begin article-title 129
Cdk2-dependent phosphorylation of Id2 modulates activity of E2A-related transcription factors
###end article-title 129
###begin article-title 130
Degradation of Id2 by the anaphase-promoting complex couples cell cycle exit and axonal growth
###end article-title 130
###begin article-title 131
###xml 97 102 <span type="species:ncbi:10090">mouse</span>
Expression patterns of Id1, Id2, and Id3 are highly related but distinct from that of Id4 during mouse embryogenesis
###end article-title 131
###begin article-title 132
Centrosomes as command centres for cellular control
###end article-title 132
###begin article-title 133
###xml 151 156 <span type="species:ncbi:9606">human</span>
p21(cip-1/waf-1) deficiency causes deformed nuclear architecture, centriole overduplication, polyploidy, and relaxed microtubule damage checkpoints in human hematopoietic cells
###end article-title 133
###begin article-title 134
Mitotic infidelity and centrosome duplication errors in cells overexpressing tripeptidyl-peptidase II
###end article-title 134
###begin article-title 135
Excessive centrosome abnormalities without ongoing numerical chromosome instability in a Burkitt's lymphoma
###end article-title 135
###begin article-title 136
###xml 0 28 <span type="species:ncbi:333760">Human papillomavirus type 16</span>
Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype
###end article-title 136
###begin article-title 137
###xml 20 25 <span type="species:ncbi:9606">human</span>
Papillomaviruses in human cancers
###end article-title 137
###begin article-title 138
Centrosome-, chromosomal-passenger- and cell-cycle-associated mRNAs are differentially regulated in the development of sporadic colorectal cancer
###end article-title 138
###begin article-title 139
Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas
###end article-title 139
###begin article-title 140
Aurora A is differentially expressed and regulated in chromosomal and microsatellite instable sporadic colorectal cancers
###end article-title 140
###begin article-title 141
Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation
###end article-title 141
###begin article-title 142
Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase
###end article-title 142
###begin article-title 143
Aurora kinase inhibitors: a new class of targeted drugs in cancer
###end article-title 143
###begin article-title 144
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
###end article-title 144

